Cardiac Ablation Market Size By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), By Application (Cardiac Rhythm Management {Atrial Fibrillation & Flutter, Tachycardia}, Open Surgery), By End-use (Hospitals, Ambulatory Surgical Centres, Cardiac Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Industry trends

Cardiac Ablation Market size was over USD 2.8 billion in 2019 and is projected to grow at 13.1% CAGR from 2020 to 2026.
 

Get more details on this report - Request Free Sample PDF
 

Growing market demand for minimally invasive technology and rising awareness among population for effective treatment alternatives including cardiac ablation will further favour industry expansion.
 

Cardiac ablation is a procedure widely adopted for treatment of arrythmias, that can be done with minimum invasion or open surgery. This procedure involves destruction of cardiac tissues using variety of ablation devices. These devices use various energy sources such as radiofrequency, ultrasound or low temperature (cryoablation) among others to ablate damaged tissue causing irregular heartbeats. Cardiac ablation procedure is mainly used to correct abnormal electrical currents originating in the cardiac tissue. Increasing incidence of cardiovascular (CVDs) diseases coupled with growing geriatric population susceptible to CVDs will spur the overall market size.
 

Increasing number of cardiovascular patients worldwide to upsurge cardiac ablation market growth

Growing adoption of unhealthy lifestyle such as excessive alcoholism and smoking has surged the number of cardiovascular disease patients. Other factors such as diabetes mellitus, mental stress and side effects of certain medications significantly impact development of arrythmia. Moreover, increasing risk factors and advancement in treatment of cardiac rhythm disorders will propel the industry growth.
 

Rising awareness about the better healthcare services and increasing number of ablation centres will boost the overall cardiac ablation industry growth. With improving healthcare infrastructure, adoption of cardiac ablation will also surge. However, stringent regulations and risk associated with cardiac ablation procedures may hinder market opportunities during the analysis timeframe.
 

Increasing usage of radiofrequency ablation in cardiac ablation procedure will provide lucrative growth opportunities

Get more details on this report - Request Free Sample PDF
 

The product segment is bifurcated into radiofrequency ablators, electric ablators, cryoablation devices, ultrasound ablators and other devices. According to the World Health Organization (WHO), around 17 million people die from cardiovascular diseases and 85% death are due to heart attacks. Increasing incidence of these disorders will fuel the demand for cardiac ablation devices.
 

RF ablators market held USD over 1.4 billion market size in 2019. The importance of radiofrequency (RF) ablators is continuously growing owing to high effectivity of the device. In addition, RF ablators are safe, reliable, and offer option of customization during procedure, thereby increasing its preference over others. Moreover, wide availability of the device will spur the market growth in the forthcoming years.
 

Advancement in diagnosis and treatment of cardiac rhythm disorders will positively impact industry size

Get more details on this report - Request Free Sample PDF
 

Cardiac ablation market product segment covers cardiac rhythm management, open surgery and others. Cardiac rhythm management is further sub segmented into atrial fibrillation and flutter, tachycardia and other cardiac arrythmias. Cardiac rhythm management segment reported more than 13% CAGR during the forecast period. Population suffering from atrial fibrillation and flutter need efficient cardiac rhythm management, thus impelling the market demand for cardiac ablation procedures.
 

Atrial fibrillation market accounted for more than 65% of the total cardiac rhythm management application segment. Atrial fibrillation is the most commonly occurring form of cardiac arrhythmia. Ablation procedure is frequently performed on atrial fibrillation patients that are not responsive to drug therapy. With expanding geriatric pool and rising risk factors, the segment will proceed at significant rate.
 

Sophisticated infrastructure and better cardiac ablation procedural outcomes will increase procedure preference at hospitals

The end-use segment is segmented as hospitals, ambulatory surgical centres, cardiac centres and other end-users. Cardiac ablation market demand from hospitals segment accounted for over USD 1.6 billion revenue size in 2019. High impact of sophisticated healthcare infrastructure and skilled physicians will increase procedural adoption rate at hospital settings.
 

Hospitals are gaining massive popularity and will continue to show growth due to rising consumer-driven healthcare as well as availability of advanced technology in hospitals. Moreover, cardiac centres will also witness positive growth due to expanding number of cardiac centres in emerging economies and wide adoption of cardiac procedures at these centres.
 

Presence of major market players in North America proves beneficial for the market expansion

North America cardiac ablation market revenue held substantial share in 2019 and will witness around 12.9% CAGR during the analysis period. Regional growth is primarily attributed to due to presence of major market players constantly investing into research and development activities. Furthermore, increasing U.S. FDA approval for arrythmia treatment devices will also boost the market growth in the region.
 

Presence of major industry players in the U.S. and increasing incidence of cardiovascular diseases will favor the U.S. market growth. Moreover, various government initiatives to spread awareness about rhythm management and rising adoption technologically advanced products in this country will propel the market growth.
 

Prominent industry players operating in cardiac ablation are investing in R&D activities to sustain market competition

Some of the eminent business players operating in the cardiac ablation market share include Abbott Laboratories (St. Jude Medical), AtriCure Inc, Biosense Webster (Johnson & Johnson), Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic plc and Stereotaxis, Inc. among others. Prominent market players are adopting various organic and inorganic growth strategies to gain market share and sustain market competition.
 

Some of the recent industry developments:

• In January 2019, Abbott announced the FDA approval of the TactiCath sensor enabled ablation catheter. The approval helped the company to increase its customer base in the U.S. market, thus increasing its market share.
   
• In October 2019, AngioDynamics announced the acquisition of Eximo Medical, Ltd. This development helped the company to expand their vascular intervention product portfolio.
   

The cardiac ablation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market Outlook By Product

• Radiofrequency (RF) Ablators
• Electrical Ablators
• Cryoablation Devices
• Ultrasound Ablators
• Others
   

Overview By Application

• Cardiac Rhythm Management
  • Atrial Fibrillation & Flutter
  • Tachycardia
  • Others
• Open surgery
• Others
   

By end-use

• Hospitals
• Ambulatory surgical centers
• Cardiac centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia